The article focuses on the plan of biotechnology companies to invest in Australia. According to the article, Australia is the sixth largest country in the world in terms of biotechnology companies and it ranks seventh in terms of share of global biotechnology patents. In considering the plan of ...
In biotech, sometimes it's the companies that aren't making a single dime that end up being the very best investments after a short time. For instance, Viking Therapeutics (NASDAQ: VKTX) doesn't yet have any revenue. But thanks to its ongoing clinical in
In the wake of the pandemic, the emergence of the COVID-19 vaccine put a spotlight on mRNA biotechnology used by pharmaceutical companies as they raced to develop vaccines to fight off the coronavirus. Biotech companies like Moderna (ticker:MRNA) and BioNTech (BNTX) used mRNA technology to qu...
If you’re interested in biotech stock investing, there are some things you should know beforehand. A biotech company’s pipeline is everything, and it is the source of the company’s presumed and projected value. It’s important that investors try to focus their attention on companies that ...
One of the key factors that make the biotech industry unique is its heavy reliance on scientific research and development. Biotech companies invest significant resources in conducting clinical trials, obtaining regulatory approvals, and bringing their products to market. Consequently, the industry is cha...
Asabys hopes to continue to invest in companies with a strong research and development base Asabys, which counts Alantra as a strategic partner, launched the first fund four years ago with an initial target of €60 million and the support of Banco Sabadell as the main investor. Following th...
The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies
Still, if I were to put a little money where my pen is, where would I start? The mood music from Aim, my traditional hunting ground, is funereal. Aim biotech companies complain of liquidity constraints, high regulatory costs and limited access to funding. European stock market investors are...
GSK and Merck invest in biotech companies.GSK and Merck invest in biotech companies.Reports on the investment of GlaxoSmithKline PLC in a private placement by Adherex Technologies Inc. as part of a cross-licensing deal.EBSCO_AspChemical & Engineering News...
Despite having a product on the market and being identified by analysts as a potential acquisition target for several largepharmaceuticalcompanies, many European shareholders are still reluctant to invest in Belgium-based Argenx, with Scottish fund Baillie Gifford a rare exception. “I think we have ...